Digital health case studyInsurance

Sourcing HealthTech Ventures to Power Non-Fluid Underwriting

Client context: Global re-insurer

Strategic question

Which ventures across digital biomarkers, DTx, genomics and teleconsultation are mature enough to enable non-fluid underwriting?

Decision enabled

What the client could do next

Enabled the re-insurer to advance partnership evaluation with a qualified, criteria-matched shortlist.

Approach

Powered by HealthTech Alpha, we mapped two priority ecosystems, evaluated 291 ventures against underwriter-grade criteria and co-built a prioritised shortlist anchored to the client’s operational requirements.

Methodology

DefineClarified the strategic question, scope, decision owner and evaluation criteria.

MapIdentified relevant ventures, markets, competitors, partnerships and ecosystem signals.

AssessEvaluated maturity, traction, evidence, strategic fit and operational readiness.

DecideTranslated findings into a decision-ready shortlist, benchmark or recommendation.

Strategic interpretation

Converted a fragmented HealthTech landscape into a clean, underwriter-relevant set of partnership options.

Key results

2Priority markets scanned

291Ventures evaluated against criteria

41Prioritised shortlist

Structured digital health intelligence, venture evidence, and analyst interpretation for defensible decisions.

Alpha Brief

Turn this case study into your own decision brief

Answer a few prompts and request a scoped Alpha Brief for your market, portfolio, competitive intelligence, or due diligence question.

Build an Alpha Brief

Request a scoped proposal from this case

Sourcing HealthTech Ventures to Power Non-Fluid Underwriting

Which ventures across digital biomarkers, DTx, genomics and teleconsultation are mature enough to enable non-fluid underwriting?

What the client could do next

Approach

Methodology

Strategic interpretation

Overview

Category

Stage

Total Funding

GGA Score